PropertyValue
?:abstract
  • Andrew Pollard has been leading the Oxford vaccine clinical trials in the UK, Brazil, and South Africa He tells Elisabeth Mahase how the Oxford vaccine came to be, how dosing was worked out, and whether it will stand up to the new variants
?:creator
?:journal
  • BMJ_:_British_Medical_Journal_(Online)
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • How the Oxford-AstraZeneca covid-19 vaccine was made
?:type
?:who_covidence_id
  • #1027121
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/xsl2zknn>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/xsl2zknn>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all